×
Back to Agenda
Session 8: Compliance Update Panel
Session Chair(s)
Scott Liebman
Partner, Loeb & Loeb, LLP, United States
From drug pricing to First Amendment questions and completion of Corporate Integrity Agreements, companies are facing new and challenging compliance issues. This panel will explore these new trends and offer insight on how to navigate the uncertainty.
Speaker(s)
Joe Zimmerman
Former Senior Vice President, Chief Compliance Officer, Actavis & Forest, United States
Panelists
Emily Wright, JD
Senior Corporate Counsel, Pfizer, United States
Howard L. Dorfman, JD
Founder, H. L. Dorfman Pharmaceutical Consulting, United States
Have an account?